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Purpose: To evaluate usefulness of cutting needle biopsy (CNB) to recognize pediatric renal tumors and to predict
the evolution of histology during preoperative chemotherapy of Wilms tumors.
Methods:Ninety pediatric patients were operated for renal tumors at our institution in 1988–2015.We included
all 64 patients who had undergone CNB at diagnosis and whose CNB and nephrectomy samples were available
for re-evaluation.
Results: The CNBwas diagnostic in all 59Wilms tumors but only in two out of five non-Wilms tumors. Anaplasia
was missed by CNB in one of three with diffuse anaplasia in nephrectomy specimens. In Wilms tumors the
proportions of the blastemal, stromal and epithelial components were 55% (IQR 25–85), 28% (IQR 10–58) and
2% (IQR 0–10) in CNB samples and 5% (IQR 0–64), 15% (IQR 0–50) and 15% (IQR 0–44) in the nephrectomy
specimens (p-values 0.002, 0.599 and 0.005 respectively). The degree of tumor necrosis was in median 80%
(IQR 21–97), after preoperative chemotherapy. The degree of tumor necrosis after chemotherapy had a positive
correlation with the proportion of blastemal component (p= 0.008) and a negative correlation with proportion
of epithelial component in pre-chemotherapy CNB samples (p b 0.001).
Conclusions: Wilms tumors are usually recognizable unlike non-Wilms tumors in CNB at diagnosis. In Wilms
tumors, high blastemal cell content is associated with significant tumor necrosis during pre-operative
chemotherapy. Our results do not support routine use of CNB in diagnosis of renal tumors.
Type of study: Retrospective review.
Level of evidence: Level III.
© 2017 Elsevier Inc. All rights reserved.Wilms' tumor is treated primarily using strategies created by the
Wilms' tumor study (NWTSG), and its successor Children's Oncology
Group (COG) Renal Tumor Committee or by International Society of Pe-
diatric Oncology (SIOP) Renal Tumor Committee [1]. North-American
NWTS/COGprotocols are based on primary surgery followed by chemo-
therapy. This approach allows an accurate and comprehensive evalua-
tion of tumor histology. The SIOP protocol is used mainly in Europe
and an essential part of it has been preoperative chemotherapy. Duringof European Society for Pediat-
elsinki University Hospital,
58 504272542; fax: +358 9preoperative chemotherapy the tumor size shrinks and the operation
becomes easier with a decreased risk for tumor rupture [2,3]. However,
the preoperative chemotherapy may be directed to the wrong type of
tumor, if histological verification is lacking, and accurate histological
classification may occasionally be impossible from the nephrectomy
specimen because of tumor necrosis. The use of cutting needle biopsy
(CNB) was presented previously in 1991 in studies from Helsinki,
London and Toronto, followed later by Sweden [4–7]. In general, posi-
tive experience has been reported from UK from the use of cutting nee-
dle biopsies: 12% of the patients who turned out to have non-Wilms'
tumor avoided inappropriate chemotherapy [8]. The drawback of this
approach is that the primary CNB represents small foci of the tumor.
In addition, the diagnosis of anaplasia has been particularly challenging
by CNB in prior reports [8].
Diagnostic biopsy and preoperative chemotherapy have been part of
our protocol in children with a renal tumor since the initial report in
Table 1
The chemotherapy administered pre-operative for all the children. The chemotherapy
protocols used were mainly based on SIOP and NWTS protocols.
Preoperative chemotherapy (n = 59) Median, range % of Children
Dactinomycin mg/kg 0.17, 0.06–0.29 100%
Vincristine mg/m2 8.3, 1.8–25.9 100%
Doxorubicin mg/m2 53, 20–99 15%
Cyclophosphamide mg/m2 1338, 556–3375 25%
Etoposide mg/m2 368, 218–542 8%
Ifosfamide mg/m2 6824, 3034–10,784 7%
Cisplatin mg/m2 111, 111 1.7%
Fig. 1. Proportion of different cellular elements in 59Wilms tumor patients. Thewhite and
dark boxes indicate the proportion of individual component in the primary cutting needle
biopsy and the nephrectomy sample respectively.
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ings of the primary biopsy to the nephrectomy sample in order to char-
acterize the effect of the initial chemotherapy.
1. Methods
The study cohort was identified by a retrospective review of surgical
database for patients operated on for renal tumors in 1988 through
2015 at our hospital. The institutional Ethics Committee had approved
the study. Altogether 90 patients were found of whom 70 had had pre-
operative CNB. We included to the final analysis all the 64 renal tumor
patients who had both original preoperative CNB and nephrectomy his-
tology samples available. We excluded the 20 patients who had not un-
dergone preoperative CNB and six patients whose pathology slides
could not be found for re-evaluation.
The general policy of our hospital has been in favor of diagnostic
renal biopsy excluding intrarenal stage 1 tumors, cystic tumors and tu-
mors with active bleeding. CNB has been taken by using ultrasound
guidance from a posterior or flank approach avoiding the peritoneal
cavity. In the early series manually used Tru-Cut™ cutting needles
were used but have been replaced by automatic cutting needles (now-
adays: BioPince® 18ga; Argon Medical Devices, TX, USA) during the
last 20 years. CNB has been repeated each time until at least two
acceptable-quality cylinders were collected.
The pathology slides were re-evaluated by an experienced pediatric
pathologist (JL) together with senior pediatric oncologist (MT) to con-
firm the diagnosis and to classify the response to preoperative chemo-
therapy according to current guidelines [9]. In case of Wilms' tumor
the structured histological evaluation included the estimation of the de-
gree of necrosis (necrotic= 100% necrosis, regressive= 66–99% necro-
sis, poor response = necrosis b66%), proportions of cellular
components of Wilms' tumor (epithelial, blastemal, stromal) expressed
as a percent of the total surface area of the viable tissue of the tumor,
and presence of anaplasia (focal or diffuse) [9].
The complications of the tumor biopsy or nephrectomyaswell as the
cumulative doses of preoperative chemotherapy agents were collected
from the patient charts. Preoperative chemotherapy was based on vin-
cristine and actinomycin D. According to the institutional policy during
the early years of the evaluation period, either cyclophosphamide or
doxorubicin was used in preoperative chemotherapy of metastatic,
anaplastic or blastemal predominance Wilms' tumors (Table 1). WeTable 2
Occurrence of differentWilms's tumor cellular elements from cutting needle biopsy (CNB)
at diagnosis and from nephrectomy after preoperative chemotherapy. The figures in
parenthesis indicate the frequency of the component in the CNB or nephrectomy sample
only.
Cellular components CNB sample Nephrectomy specimen p-value
Wilms tumor 59 59
Blastemal cells (n) 55 (17) 40 (2) b0.001
Epithelial cells (n) 36 (5) 44 (13) 0.168
Stromal cells (n) 45 (13) 37 (5) N0.99
Anaplasia 3 (1) 6⁎ (4)
⁎ Three patients had diffuse anaplasia and three had focal anaplasia.evaluated the response to preoperative chemotherapy by analyzing
the proportion of tumor necrosis at the time of nephrectomy.
1.1. Statistical analysis
Existence of different cellular components in the CNB and in ne-
phrectomy samples were compared by using Fisher's exact test and
the change in theproportions of the cellular componentswithWilcoxon
signed rank test. The association between different cellular components
on CNB and the degree of necrosis was evaluatedwith linear regression.
Continuous variables are expressed asmedians and interquartile ranges
(IQR) or ranges. For the analyses Statview® 5.0.1, SAS Institute Inc. was
used. p b 0.05 was considered significant.
2. Results
2.1. Patient characteristics
Twenty-nine of the 64 patients were male. The median age at diag-
nosis was 3.1 years (IQR 1.8–4.5, range 0.1–17.1). The tumor was locat-
ed on the right or left side, or bilaterally in 33 (52%), 27 (42%) and four
(6%) patients, respectively. Fifteen patients (23%) presented with lung
metastases at diagnosis and five (8%) had tumor thrombus extending
to the vena cava (3 with lung metastases) and one patient had a
tumor extending to the ureter.
2.2. Complications of CNB and nephrectomy
CNB was safe: one patient required a blood transfusion because of
bleeding and three patients had hematuria caused by CNB. No other se-
vere side effects were noted. We did not have a tumor rupture during
nephrectomy and previous CNB did not complicate nephrectomy and
tumor growth was not observed in the CNB tract.
2.3. Histology in CNB and nephrectomy samples
Originally 61 tumors got Wilms' tumor diagnosis by CNB. However,
after nephrectomy one of them turned out to be clear cell carcinoma
and another was primitive neuroectodermal tumor. In the re-
evaluation, both of these false positive CNBs were found to be insuffi-
cient for diagnosis. CNB was considered non-diagnostic both in initial
and in re-evaluation in one additional clear cell sarcoma case. The sen-
sitivity of CNB samples both in the original and in this study evaluation
Fig. 2. The association of the degree of necrosis seen in the nephrectomy specimen after chemotherapy compared with the proportion of blastemal, epithelial or stromal tumor in CNB.
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Wilms' tumors could be diagnosed correctly in CNB samples, these two
diagnostic biopsies were a mesoblastic nephroma and the other was a
malignant rhabdoid tumor.
InWilms' tumors blastemal and stromal componentsweremore fre-
quently found in the CNB than in nephrectomy specimens in contrast to
the epithelial component (Table 2). Eleven of the diagnostic CBN speci-
mens were solely composed of one histological component that being
blastemal in 9 samples and epithelial or stromal in one sample each. Dif-
fuse anaplasiawas observed in three nephrectomy samples (5%). In two
of these three cases anaplasia was observed in the diagnostic CNB
samples.
The median percentage of blastemal, stromal and epithelial compo-
nents in the diagnostic CNB inWilms' tumorswas 55% (IQR 25–85), 28%
(IQR 10–58) and 2% (IQR 0–10), respectively (Fig. 1). The preoperative
chemotherapy resulted in a significant decrease in the proportion of
blastemal and an increase in the proportion of epithelial element be-
tween the CNB and nephrectomy specimens (p = 0.002 and 0.005
respectively).
The proportion of necrosis seen in the tumors was 80% (IQR 21–97)
in the nephrectomy samples. The nephrectomy specimens were classi-
fied as fully necrotic and regressive in 10% and 44% respectively [9]. The
specimens with least necrosis were of mixed, blastemal, stromal or ep-
ithelial type in 20%, 7%, 13% and 5% of cases. A high blastemal cell per-
centage in the CNB was associated with a high proportion of necrosis
and a high epithelial cell content was associated with low proportion
of tumor necrosis after preoperative chemotherapy (p = 0.008 and
b0.001, respectively, Fig. 2).2.4. Chemotherapy
Tumors with high percentage of blastemal component (N50%) in
CNB responded well (median percentage of necrosis 80%) to preopera-
tive chemotherapy including vincristine and dactinomycin alone. The
addition of alkylating agents or anthracycline did not increase the pro-
portion of necrosis in these blastemal-rich WTs (median percentage of
necrosis 97%) (p=0.49). The response to VD alone (median percentage
of necrosis 50%) vs. VDA (median percentage of necrosis 20%) was sim-
ilar also among patients with blastemal-poor WTs (p = 0.88).3. Discussion
CNBs were diagnostic in all Wilms' tumor cases both in initial report
and in re-evaluation, given that the sample sizewas sufficient. However,
CNBs were non-diagnostic in three out of the five non- Wilms' cases in
re-evaluation. No false negative samples were observed in the re-
evaluation. Accordingly, no inter-examiner bias was observed in the in-
terpretation of the histological samples of classical Wilms' tumor. The
non-Wilms' tumors were more difficult to diagnose in CNB samples
and both clear cell sarcoma cases and the primitive neuroectodermal
tumor remained undefinable in CNB samples. In classical Wilms' tu-
mors, the high proportion of blastemal cell content in CNBwas associat-
ed with a large degree of tumor necrosis during pre-operative
chemotherapy. In contrast, a high percentage of stromal and especially
a high proportion of epithelial component was associated with less
tumor necrosis with pre-operative chemotherapy. Consequently, the
proportion of blastemal cells decreased and the proportion of epithelial
cells increased in response to the pre-operative chemotherapy.
In our study, nephrectomy confirmed Wilms' tumor diagnosis in all
59 cases but only two of the five non-Wilms' tumorswere diagnosed by
CNB. Similarly, in a study from Sweden all classical Wilms' tumors were
found in CNBs, but only one third of non-Wilms' tumors were correctly
diagnosed with CNB [7]. As well, anaplasia is challenging to find, both in
biopsy and nephrectomy samples. In our study two of the three patients
with diffuse anaplasia had signs of anaplasia in CNB samples and simi-
larly in the UK study only 4 out 17 patients with anaplasia were found
in CNB [8]. There are also substantial difficulties to find diffuse anaplasia
in nephrectomy samples without preoperative chemotherapy; 39% of
the cases detected in central review were not originally found by local
pathologist in NWTS study [10].
Blastemal cellular component was the most common component in
CNB found in 93% of the Wilms' tumors in our patients. This is in line
with a previous UK study where 89% of the CNBs of Wilms' tumors pa-
tients showed blastemal component [8]. However, blastemal compo-
nent was less frequent in post-chemotherapy samples, 68% in our
study and 49% in the UK study. The proportion of stromal element de-
creased from 76% to 63% and the proportion of epithelial element in-
creased from 61 to 75% in our patients. In the study of Vujanic et al.
the decrease was from 66% to 41% in stromal elements and from 42%
to 40% in epithelial elements [8]. The results are also in line with SIOP-
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patients with immediate surgery, but rare (9.3%) in patients who had re-
ceived preoperative chemotherapy whereas regressive changes became
common with chemotherapy [11–13]. In SIOP-9 study total necrosis of
the tumor was associated with greater volume reduction and better sur-
vival [14]. Our study differs from SIOP study by evaluating patients' histo-
pathology before and after chemotherapy in contrast to comparing
patientswithno chemotherapy versus chemotherapy group, but themes-
sage is similar despite in SIOP study the patientswere younger and the tu-
mors smaller in in no chemotherapy group [13].
In our study, tumorswith a high percentage of blastemal component
(N 50%) responded well to pre-operative chemotherapy consisting of
vincristine and dactinomycin alone. The addition of alkylating agents
or anthracycline did not increase the proportion of necrosis in the
blastemal-rich WTs. This observation from the early series is in line
with current practice.
Preoperative chemotherapymay have contributed to safer nephrec-
tomy since we did not have any tumor ruptures during surgery despite
of sizeable tumors. This is in accordance to a recent randomized study
fromUK, inwhich no per-operative tumor ruptures occurred in patients
with preoperative chemotherapy compared to 14.6% rupture rate in the
patients undergoing immediate nephrectomy without chemotherapy
[3]. Avoiding tumor rupture and accordingly radiotherapy is of great im-
portance in respect of late effects of cancer therapy in small children.
In our series only one patient needed intervention, transfusion of the
red blood cells, because of biopsy. In a previous study, evaluating com-
plications after biopsy 19% of the patients experienced post-biopsy
pain, 20% had a fall in hemoglobin, 0.5% needed emergency nephrecto-
my due tomassive bleeding, 0.5% had tumor rupture perhaps unrelated
to the biopsy and 0.5% got tumor recurrence to the needle track
8 months after the biopsy [8]. Needle tract seeding may be a real risk
after percutaneous biopsy [15,16]. Thin 18-gauge needle may decrease
the risk of the needle track recurrence after biopsy [7,8]. In our study, vi-
able tumor cells in the CNB tract could not be shown in nephrectomy
samples nor were late recurrences detected.
Our study has limitations rising from its retrospective nature. How-
ever, an experienced pathologist re-evaluated all the histological sam-
ples to cover the possible inter-examiner bias of the histological
findings. Because of the heterogeneous nature of the Wilms' tumor,
some cellular elements with small percentage are easily missed in CNB
decreasing the value of the biopsy. However, our study shows that
some cellular elements, especially blastemalmay disappearwith chemo-
therapy. Thus, biopsy and nephrectomy samples seem to give supple-
mentary information. Another source of bias may be due to changes in
chemotherapy during the study period. We have attempted to control
this bias by calculating the cumulative doses of the chemotherapy agents
and by evaluating the effect of standard chemotherapy with vincristine
and dactinomycin alone or in combination with of alkylating agents or
anthracycline both in blastemal-rich and -poor tumors.We conclude that primary chemotherapy before nephrectomy will
result in a median 80% necrosis of the Wilms' tumor. Best response
was seen in blastemal and worst response in epithelial cellular type.
However, intensifying preoperative chemotherapy regimen seems not
to bring more response in blastemal-rich or blastemal-poor Wilms' tu-
mors, which is in line with current treatment policy. Anaplastic ele-
ments and other cellular elements with small volume are easily
missed in the diagnostic CNB and non-Wilms' tumors are difficult to
recognize. Our study does not support the routine need of core needle
biopsy in guidance of pediatric renal tumor pre-operative chemothera-
py, but still CNB can be of help in cases with unclear imaging findings if
an experienced pathologist is available.References
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